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Results: Texture parameters were computed in the three 
perfusion maps and their 3D wavelet transforms, which 
resulted in 945 texture features defined for each of the two 
tumor sites. The discretization of images using set number of 
bins and setintervals gave the similar number of stable 
texture parameters (Table 1). 40 parameters were correlated 
with tumor volume. Potentially standardizable factors 
introduced more variability into texture features than non-
standardizable. The highest variability was observed for pixel 
size. It caused instability in about 80% of parameters for both 
HN and lung tumors. Ten parameters were found to bestable 
in both HN and lung for potentially non-standardizable 
factors after thecorrection for inter-parameters correlations:  
 
• BF: entropy, sum entropy, LHH low gray-level size 
emphasis 
• MTT: long size low gray-level emphasis 
• BV: difference entropy, coarseness, long size high 
gray-level emphasis, HLH information measure of 
correlation 2, LLL covariance, LLLaverage. 
 
 
 
Conclusion: The set of stable texture parameters in CTP was 
identified. Pixel size, image discretization and HU intervals 
have to be standardized to build a reliable prediction models 
based on CTP texture analysis. 
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Purpose or Objective: The aim of the study was to employ 
texture analysis to predict early stage Hodgkin Lymphoma 
(HL) patients’ outcome after chemotherapy and to give a 
quantitative description of HL characteristics. Predicting an 
early cancer's response to chemotherapy could enhance 
clinical care management by enabling the personalization of 
treatment plans based on predicted outcome.  
 
Material and Methods: We reviewed medical records of 
patients with early stage HL diagnosed between January 2012 
and December 2014 treated with standard combined modality 
therapy. 24 pre-treatment PET scans of the patients, 
acquired with a GE discovery STE, were selected for the 
analysis. A local nuclear medicine physician, blinded for the 
clinical outcome and interim PET (iPET) results, reviewed all 
PET scans. Volume of Interests (VOIs) were segmented 
employing cubes of volume 27 cm3 and 64 cm3 and centering 
them on the highest metabolic active mediastinic area. 
Texture analysis (TA) was applied through CGITA open source 
software and TA features correspondence with iPET results 
was assessed. Furthermore, we segmented isolated 
lymphnodes with a 40% of SUVmax isocontour algorithm. Each 
lymphnode was analyzed with TA as a “stand-alone patient” 
in order to increase the number of observations. TA features 
correspondence with iPET outcome of each lymphnode was 
assessed. Kruskall Wallis non-parametric test was employed 
to select most predictive features. Features, which showed 
prognostic power (or patient stratification ability), were 
employed to build Receiver Operating Curve (ROC) in order to 
score their sensibility and specificity. 
 
Results: After iPET revision, 17 patiets were considered 
disease free after 2 cycles of ABVD whereas the remaining 7 
patients had a positive iPET. Results obtained employing the 
27 cm3 cubes showed that 4 features are able to predict iPET 
response with statistical significance (p<0.02) and a high 
efficiency up to 85% employing “uniformity feature”. Using 
64 cm3 cubes, we were able to isolate a feature named short 
zone emphasis, which has a discrimination sensibility of 100% 
with specificity 65% and indicates for ABVD resistant tumors 
the presence of short active zone in the surrounding of the 
mediastinic region highest metabolic active area. Lymphnode 
analysis showed that 5 out of 74 TA features could separate 
iPET responders and non-responders patients with statistical 
significance (p<0.01). In particular, “coarseness” feature has 
a discrimination efficiency of 73% (sensibility 77% and 
specificity 70%). Patients with lymphnodes that appear 
coarser have a higher probability of being positive at iPET. 
 
Conclusion: In this work we presented a method to predict 
early stage HL patient outcome and to quantitatively 
describe tumor morphology combining textural features. This 
method requires further validation in larger prospective 
study. 
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Purpose or Objective: Dynamic contrast-enhanced Computed 
Tomography (DCE-CT) is a quantitative imaging modality to 
characterize heterogeneity in tumour vascularization. 
Problems in DCE-CT kinetic modelling have been reported 
due to lung tumour enhancement arriving prior to aortal 
enhancement. Studies have attempted to correct the issue by 
shifting the enhancement curve in time, segmenting different 
input vessels and/or dual-input kinetic modelling. The 
purpose of this project was to develop a methodology for a 
detailed spatio-temporal analysis of the heterogeneous lung 
tumour enhancement for the purpose of applying different 
input vessels in kinetic modelling. 
 
Material and Methods: Nine patients with non-small cell lung 
cancer (NSCLC) received DCE-CT scans (Siemens Definition 
Flash) prior to radiation therapy using shuttle mode 
acquisition with a longitudinal FOV of 13 cm. The DCE-CT 
scans were first motion corrected (Siemens VPCT) and 
subsequently, the primary lung tumour was contoured by a 
radiation oncologist. Using an in-house model, tumour and 
aorta time attenuation curves were analysed by gamma-
variate function fitting. The arrival time of the contrast 
agent was estimated by a threshold of 1% of the maximum 
enhancement of the fit. To determine the percentage of 
tumour enhancement prior and after aortic enhancement, 
the arrival times of the gamma-variate fit of the tumour and 
aorta were compared. Tumour voxels were considered 
acausal if the arrival time was greater than 2 s before the 
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aorta arrival time, to correct for acquisition time differences 
and fitting uncertainties. 
 
Results: Gamma-variate fitting was able to capture contrast 
arrival time in the DCE-CT images for all 9 patients. Two of 
the patients displayed clear tumour enhancement prior to 
aortal enhancement. For these patients, the percentage of 
the tumour with acausal enhancement with/without a 2 s 
allowance was 64%/73% and 37%/54%. The mean and standard 
deviation of the enhancement time differences between the 
tumour voxels with acausal enhancement and the aorta 
with/without a 2 sec allowance were -1.8 s ± 0.6 s/-3.4 s ± 
1.1 s, and -1.4 ± 0.6 s/-2.6 ± 1.3 s, for each patient. 
 
 
 
Conclusion: Our study found apparent acausal enhancement 
in lung tumours in relation to the aorta for a subset (22%) of 
the NSCLC patient population examined. For these patients, 
gamma-variate fitting was able to determine both the 
percentage of the tumour with acausal enhancement times 
and the effective enhancement time difference between the 
tumour voxels and the aorta. These findings highlight the 
tumor vascular heterogeneity and warrant new kinetic 
analysis models to incorporate different tumor enhancement 
analysis and the selection of an appropriate input function. 
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Purpose or Objective: PET scanners are used for several 
decades in a wide range of diagnostic experiments. In the 
treatment of thyroid cancer with I-131, quantitative 
information of a PET scan using I-124 is used to determine 
the release dose to the tumor and critical organs during the 
treatment. To guarantee comparison of absolute 
quantification among institutes, measurements have to come 
along with uncertainty estimates and have to be traceable 
(i.e. linked) to international measurement standards. 
However, despite recent advances, PET/CT calibrations are 
not traceable to any measurement standard. As a result, 
scans taken at different scanners are not or hardly 
comparable with each other. 
 
Material and Methods: VSL (National Metrology Institute in 
The Netherlands) maintains and develops the national 
measurement standards, and is able to supply support to the 
development of calibration chains and standard measurement 
protocols, thereby guaranteeing traceability to 
internationally accepted measurement standards. The 
purpose of this project is to develop a metrological 
infrastructure and service for on-site calibration of PET/CT 
scanners. VSL has the facilities to measure the activity of 
radionuclide solutions in a secondary level traceable to the 
primary standard at NPL (National Metrology Institute in UK). 
In 2012 and 2013 in the context of a large national multi-
center trial (19 hospitals), a hospital in The Netherlands has 
performed non-traceable inter-comparison for I-124. 
Traceable measurements to validate concept method have 
been performed by VSL in 2015 for few scanners in The 
Netherlands. A cylindrical PMMA phantom including 6 holes to 
position vials of I-124 has been used. Activities inside the 
vials have been standardized using the secondary standard at 
VSL with an uncertainty in the range of 2.5% (k=2). Then the 
phantom has been measured in different scanners. 
 
Results: The results show differences between the measured 
activities in two setups which is typically around 40% for 
activities around 1 MBq, however goes rapidly high by 
lowering the activity. 
 
Conclusion: PET/CT calibrations for I-124 are not traceable 
to any measurement standard. The reason is lack of any 
calibration chain and protocol. Calibration measurements 
have been introduced and examined for few PET/CT 
scanners. The results of these measurements strongly 
propose the need of traceable calibration chain.  
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Purpose or Objective: To compare the dosimetric 
differences between jaw tracking (JT) and non-jaw-tracking 
(nJT) techniques in volumetric-modulated arc therapy (VMAT) 
for Hepatocellular Carcinoma (HCC) treatment. 
 
Material and Methods: The dose distribution around critical 
organs close to the tumor in HCC is critical owing to its high 
fractionation dose in Stereotactic Body Radiation Therapy 
(SBRT). Varian TrueBeam™ (Varian Medical Systems) system 
provides the JT technique, which keeps the main jaws of the 
LINAC dynamically as close as possible to the MLC aperture 
during dose delivery, hence minimize the leakage and 
transmission of the MLC and further reduces the dose to the 
organ at risk (OAR). In order to validate the advantage of 
OAR dose sparing by using JT technique in SBRT for HCC, 
treatment plans using JT and nJT techniques were designed 
for dosimetric comparison. Fifteen HCC patients were 
selected, all treated with doses of 50 Gy in 5 daily fractions 
with VMAT using 10 MV FFF beams. The maximum dose rate 
enabled for FFF beams is 2400 MU/min for 10 MV. Each VMAT 
plan was individually designed using two full and one partial 
arcs with collimator rotation of 30˚  and 330 ˚ to obtain the 
best adherence to planning objectives for each patient. All 
dose distributions were computed with the Analytical 
Anisotropic Algorithm (AAA, version 13.6) implemented in the 
Eclipse planning system with a calculation grid resolution of 
2.5 mm. Planning objectives to target coverage aimed to 
cover CTV with 100% and PTV with at least 95% of the 
prescribed dose. The main OARs considered were: spinal 
cord, kidneys, stomach, duodenum, small bowel, chest wall 
and liver. JT and nJT Planning were performed with the same 
objectives constraint while plan optimization and the mean 
doses of OARs were obtained for plan comparison. 
 
Results: At the same CTV and PTV dose coverage, every 
comparative result shows that JT plan did lower the dose 
received by OAR and improve the dose fall-off around the low 
dose region. The significant OAR dose reduction for the JT 
plan in this study are as follows: the mean doses to the liver 
was 130cGy less, the V15 of liver was 100 c.c. smaller, the 
maximum spinal cord dose was 300 cGy lower, and the mean 
kidney dose was 200 cGy lower than that in the nJT plan. 
 
Conclusion: JT technique did show superior OARs sparing 
than nJT plans in HCC. The dose reduction is of clinical 
importance, especially for high fractionation dose SBRT 
treatment. 
 
 
 
 
